| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Sa | Second HeLa Lawsuit Resolved As Novartis Reaches Confidential Settlement | 3 | Benzinga.com | ||
| Sa | Wave Life Sciences Ltd. (WVE): A Bull Case Theory | 2 | Insider Monkey | ||
| Sa | Novo Nordisk erhält FDA-Zulassung für Sogroya in drei neuen pädiatrischen Indikationen | 126 | Investing.com Deutsch | ||
| Sa | New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd., CitroTech, Vivos Therapeutics, Inc., and Virtuix Holdings on Bloomberg Television Tonight at 6:30 PM EST | 388 | ACCESS Newswire | The Show Will Also Air Across Latin America and MENA 1230 pm local time. NEW YORK CITY, NEW YORK / ACCESS Newswire / February 28, 2026 / New to The Street will broadcast nationally tonight at 6:30 PM... ► Artikel lesen | |
| Sa | Bayer ramps up hybrid seed output for Philippines, other markets | 23 | Philstar.com | ||
| Sa | Novo posts worst monthly decline as Lilly extends lead | 49 | Seeking Alpha | ||
| Sa | Harrow, Inc. (HROW): A Bull Case Theory | 2 | Insider Monkey | ||
| Sa | Benzinga Bulls And Bears: Rocket Lab, Kosmos Energy, Novo Nordisk - And Nvidia Fails To Boost Markets | 52 | Benzinga.com | ||
| Sa | NEWRON PHARMACEUTICALS SPA im strukturellen Fokus | 4 | Maximilian Berger | ||
| Sa | Cannabist Company Holdings Inc (The): Cannabist extends forbearance agreement until March 6 | 9 | Stockwatch | ||
| Sa | Novo's woes in spite of Ozempic's growth | 105 | RTE.ie | ||
| Sa | Prothena To Buy Back Up To $100 Mln Of Shares | 4 | RTTNews | ||
| Sa | Simply Solventless Concentrates Ltd: Simply Solventless begins restructuring process | 1 | Stockwatch | ||
| Sa | Josh Gottheimer makes key trades in Gilead Sciences and Intercontinental Exchange | 6 | Investing.com | ||
| Sa | Innocan Pharma Corp (2): Innocan receives FDA CVM sponsor fee waiver for LPT-CBD | 48 | Stockwatch | ||
| Sa | Vireo Growth Inc: SEC defendant Carey settles insider trading charges | 1 | Stockwatch | ||
| Sa | Verano Holdings Corp: SEC defendant Carey settles insider trading charges | 1 | Stockwatch | ||
| Sa | US IPO Weekly Recap: Asthma-focused Generate Biomedicines closes out February IPO market | 4 | Renaissance Capital | ||
| Sa | Here's Why I Won't Touch Teva Pharmaceutical With a 10-Foot Pole | 7 | The Motley Fool | ||
| Fr | Harrow Health Q4 2025 Earnings Preview | 3 | Seeking Alpha |
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| NOVO NORDISK | 5 | 40 | -0,24 % | Novo Nordisk: Nächster Nackenschlag | Im aufstrebenden Adipositas-Markt droht der dänische Biopharma-Riese Novo Nordisk weiter hinter den US-Wettbewerber Eli Lilly zurückzufallen. Neue Daten zum Hoffnungsträger CagriSema sorgen erneut für... ► Artikel lesen | ||
| BAYER | 3 | 36 | +0,39 % | Bayer Aktie: Kursrally am absoluten Limit - droht jetzt der große Rücksetzer? | © Foto: sbDie Bayer-Aktie hat in kurzer Zeit eine beeindruckende Aufholjagd hingelegt. Vom Tief bei unter 20 Euro schoss der Kurs auf knapp 50 Euro - mehr als eine Verdopplung. Klingt gut, aber genau... ► Artikel lesen | ||
| ELI LILLY | 1 | 125 | -0,11 % | Opening Bell: Coca-Cola, Nvidia, Eli Lilly, Novo Nordisk, Vistra Energy, Energy Fuels | An der Wall Street richtet sich die Aufmerksamkeit mal wieder auf die Zollpolitik von Donald Trump. Der Supreme Court hatte am Freitag die bisherigen Maßnahmen gekippt. Trump mit neuen Zöllen unter... ► Artikel lesen | ||
| NOVARTIS | 1 | 105 | +0,21 % | dpa-AFX-Überblick: UNTERNEHMEN - Die wichtigsten Meldungen vom Wochenende | GESAMT-ROUNDUP 2: Kommt eine Social-Media-Altersgrenze ab 14 Jahren? STUTTGART - Ein Mindestalter für soziale Medien wie Tiktok und Instagram zum Schutz von Kindern und Jugendlichen rückt immer näher.... ► Artikel lesen | ||
| MEDICUS PHARMA | 1 | 12 | +12,50 % | New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd., CitroTech, Vivos Therapeutics, Inc., and Virtuix Holdings on Bloomberg Television Tonight at 6:30 PM EST | The Show Will Also Air Across Latin America and MENA 1230 pm local time. NEW YORK CITY, NEW YORK / ACCESS Newswire / February 28, 2026 / New to The Street will broadcast nationally tonight at 6:30 PM... ► Artikel lesen | ||
| HARROW | 1 | 4 | +0,44 % | Harrow, Inc. (HROW): A Bull Case Theory | |||
| WAVE LIFE SCIENCES | 1 | 2 | -1,69 % | Wave Life Sciences Ltd.: Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | On track for INLIGHT clinical data update in 1Q 2026; fat loss similar to GLP-1 observed at three months and expected to continue over time and with higher doses of WVE-007 (INHBE GalNAc-siRNA), while... ► Artikel lesen | ||
| NEWRON PHARMACEUTICALS | 1 | - | -1,90 % | NEWRON PHARMACEUTICALS SPA im strukturellen Fokus | |||
| CANNABIST COMPANY | 1 | - | 0,00 % | Cannabist Company Holdings Inc (The): Cannabist extends forbearance agreement until March 6 | |||
| PFIZER | - | 92 | -0,17 % | Pfizer, Astellas Pharma Share Positive Data From Bladder Cancer Trial | NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and Astellas Pharma Inc., Friday announced the positive results from the Phase 3 EV-304 clinical trial for PADCEV in combination with Keytruda in... ► Artikel lesen |
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| DOCMORRIS AG | 5,675 | 8,88 | +56 % | 4 | 5 | 3 | |||
| NOVO NORDISK A/S | 31,600 | 41,34 | +31 % | 22 | 22 | 4 | |||
| SCHOTT PHARMA AG & CO KGAA | 14,780 | 18,70 | +27 % | 8 | 16 | - | |||
| SANOFI SA | 81,41 | 97,62 | +20 % | 15 | 18 | - | |||
| MERCK KGAA | 128,60 | 140,50 | +9 % | 9 | 3 | - | |||
| ELI LILLY AND COMPANY | 889,90 | 968,78 | +9 % | 1 | - | - | |||
| BAYER AG | 42,010 | 43,36 | +3 % | 20 | 13 | 1 | |||
| PFIZER INC | 23,350 | 23,83 | +2 % | 1 | 6 | - | |||
| ROCHE HOLDING AG GS | 402,50 | 382,67 | -5 % | 12 | 22 | 5 | |||
| ASTRAZENECA PLC | 177,25 | 163,18 | -8 % | 20 | 1 | 5 | |||
| GSK PLC | 25,040 | 22,25 | -11 % | 4 | 13 | 12 | |||
| NOVARTIS AG | 142,44 | 126,17 | -11 % | 8 | 10 | 2 |